Diagnostic Histopathology
Volume 15, Issue 1 , Pages 33-41 , January 2009

Post-mortem toxicology of commonly-abused drugs

References 

  1. Statistics on drugs misuse: England – NHS Information Centre. Also available at: http://www.ic.nhs.uk/pubs/drugmisuse07April 23, 2007;
  2. Steentoft A, Teige B, Holmgren P, et al. Fatal poisoning in nordic drug addicts in 2002. Forensic Sci Int. 2006;160:148–156
  3. Bachs L, Mørland H. Acute cardiovascular fatalities following cannabis use. Forensic Sci Int. 2001;124:200–203
  4. Drug-related deaths in Scotland in 2007. General Register Office for Scotland; 7th August 2008;Also available at: http://www.gro-scotland.gov.uk/statistics/publications-and-data/drug-related-deaths/drug-related-deaths-in-scotland-2007/
  5. Morgan O, Griffiths C, Toson B, Rooney C, Majeed A, Hickman M. Trends in deaths related to drug misuse in England and Wales, 1993–2004. Health Stat Q. 2006;31:23–27Also available at: http://www.statistics.gov.uk/downloads/theme_health/HSQ31.pdf
  6. Fendrich M, Johnson TP, Wislar JS, Hubbell A, Spiehler V. The utility of drug testing in epidemiological research: results from a general population survey. Addiction. 2004;99:197–208
  7. Jönsson AK, Holmgren P, Druid H, Ahlner J. Cause of death and drug use pattern in deceased drug addicts in Sweden, 2002–2003. Forensic Sci Int. 2007;169:101–107
  8. Man LH, Best D, Gossop M, Stillwell G, Strang J. Relationship between prescribing and risk of opiate overdose among drug users in and out of maintenance treatment. Eur Addict Res. 2004;10:35–40
  9. National programme on Substance Abuse Deaths (np-SAD) . 18th Surveillance Report: January–June 2006-Inquests into drug-related deaths reported by Coroners in England, Wales, Northern Ireland, Guernsey, Jersey and the Isle of Man & Procurators Fiscal in Scotland. St George’s, University of London: International Centre for Drug Policy; 2007;Summary: http://www.mbland.sghms.ac.uk/dms/7818277BBE9C762E703761A34C6A7E86.pdf
  10. Drummer OH. Postmortem toxicology of drugs of abuse. Forensic Sci Int. 2004;142:101–113
  11. Spiehler VR. Statistical approaches to accuracy in drug screening. In:  Sunshine I editors. Recent developments in therapeutic drug monitoring. New York: Marcel Dekker Inc; 1992;p. 671–676
  12. Ellison SLR, Gregory S, Hardcastle WA. Quantifying uncertainty in qualitative analysis. Analyst. 1998;123:1155–1161
  13. Mil’man BL, Konopel’ko LA. Uncertainty of qualitative chemical analysis: general methodology and binary test methods. J Anal Chem. 2004;59:1128–1141
  14. Pounder DJ, Jones GR. Post-mortem drug redistribution – a toxicological nightmare. Forensic Sci Int. 1990;45:253–263
  15. Leikin JB, Watson WA. Post-mortem toxicology: what the dead can and cannot tell us. J Toxicol Clin Toxicol. 2003;41:47–56
  16. Ferner RE. Post-mortem clinical pharmacology. Br J Clin Pharmacol. 2008;66:430–443
  17. McCance-Katz EF, Price LH, McDougle CJ, et al. Concurrent cocaine-ethanol ingestion in humans: pharmacology, physiology, behavior, and the role of cocaethylene. Psychopharmacology (Berl). 1993;111:39–46
  18. Harris DS, Everhart ET, Mendelson J, Jones RT. The pharmacology of cocaethylene in humans following cocaine and ethanol administration. Drug Alcohol Depend. 2003;72:169–182
  19. Pan WJ, Hedaya MA. Cocaine and alcohol interactions in the rat: effect of cocaine and alcohol pre-treatment on cocaine pharmacokinetics and pharmacodynamics. J Pharm Sci. 1999;88:1266–1274
  20. Ruttenber AJ, Kalter HD, Santinga P. The role of ethanol abuse in the etiology of heroin-related death. J Forensic Sci. 1990;35:891–900
  21. Kovaleva J, Devuyst E, De Paepe P, Verstraete A. Acute chlorophenylpiperazine overdose: a case report and review of the literature. Ther Drug Monit. 2008;30:394–398
  22. Flanagan RJ, Connally G, Evans MJ. Analytical toxicology: guidelines for sample collection postmortem. Toxicol Rev. 2005;24:63–71
  23. De Letter KA, Bouche MP, Van Boxclaer JF, Lambert WE, Piette MH. Interpretation of a 3,4-mehtylenedioxymethamphetamine (MDMA) blood level: discussion by means of a distribution study in two fatalities. Forensic Sci Int. 2004;141:85–90
  24. Pélissier-Alicot AL, Gaulier JM, Dupius C, et al. Post-mortem redistribution of three beta-blockers in the rabbit. Int J Legal Med. 2006;120:226–232
  25. Yarema MC, Becker CE. Key concepts in post-mortem drug redistribution. Clin Toxicol (Phila). 2005;43:235–241
  26. Schloegl H, Dresen S, Spaczynski K, Stoertzel M, Wurst M, Weinmann W. Stability of ethyl glucuronide in urine, post-mortem tissue and blood samples. Int J Legal Med. 2006;120:83–88
  27. Beránková K, Mutnanská K, Balíková M. Gamma-hydroxybutyric acid stability and formation in blood and urine. Forensic Sci Int. 2006;161:158–162
  28. Flanagan RJ, Connally G. Interpretation of analytical toxicology results in life and at postmortem. Toxicol Rev. 2005;24:51–62
  29. Fandiño AS, Toennes SW, Kauert GF. Studies on in vitro degradation of anhydroecgonine methyl ester (methylecgonidine) in human plasma. J Anal Toxicol. 2002;26:567–570
  30. Cone EJ, Weddington WW. Prolonged occurrence of cocaine in human saliva and urine after chronic use. J Anal Toxicol. 1989;13:65–68
  31. Tegeder I, Geisslinger G, Lötsch J. Therapy with opioids in liver or renal failure. Schmerz. 1999;13:183–195
  32. Säwe J. High-dose morphine and methadone in cancer patients. Clinical pharmacokinetic considerations of oral treatment. Clin Pharmacokinet. 1986;11:87–106
  33. Rook EJ, Huitema AD, van den Brink W, van Ree JM, Beinen JH. Pharmacokinetics and pharmacokinetic variability of heroin and its metabolites: review of the literature. Curr Clin Pharmacol. 2006;1:109–118
  34. Copeland J, Dillon P, Gascoigne M. Ecstasy and the concomitant use of pharmaceuticals. Addict Behav. 2006;31:367–370
  35. Cairns A, Roberts ISD, Benbow EW. Characteristics of fatal methadone overdose in Manchester, 1985–94. BMJ. 1996;313:264–265
  36. Dum J, Meyer G, Hölt V, Herz A. In vivo opiate binding in tolerant/dependent mice. Eur J Pharmacol. 1979;58:453–460
  37. Farrell M, Marsden J. Acute risk of drug-related death among newly released prisoners in England and Wales. Addiction. 2008;103:251–255
  38. Hammer RP, Egimez Y, Emmett-Oglesby MW. Neural mechanisms of tolerance to the effects of cocaine. Brain Res. 1997;84:225–239
  39. Dyer JE, Roth B, Hyma BA. Gamma-hydroxybutyrate withdrawal syndrome. Ann Emerg Med. 2001;37:147–153
  40. Robinson SE. Buprenorphine-containing treatments: place in the management of opioid addiction. CNS Drugs. 2006;20:697–712
  41. Risser D, Uhl A, Oberndorfer F, et al. Is there a relationship between street heroin purity and drug-related emergencies and/or drug-related deaths? An analysis form Vienna, Austria. J Forensic Sci. 2007;52:1171–1176
  42. Barat SA, Abdel-Rahman MS. Cocaine and lidocaine in combination are synergistic convulsants. Brain Res. 1996;742:157–162
  43. Hamilton RJ, Perrone J, Hoffman R, et al. A descriptive study of an epidemic of poisoning caused by heroin adulterated with scopolamine. J Toxicol Clin Toxicol. 2000;38:597–608
  44. Nogué S, Sanz P, Munné P, de la Torre R. Acute scopolamine poisoning after sniffing adulterated cocaine. Drug Alcohol Depend. 1991;27:115–116
  45. Robinson BV, Stradling JR, Davies RJO, Roberts ISD. Post-mortem diagnosis of fatal sleep apnoea. Histopathology. 2004;45:542–544
  46. Egred M, Davis GK. Cocaine and the heart. Postgrad Med J. 2005;81:568–571
  47. Yeo KK, Wijetunga M, Ito H, et al. The association of metamphetamine use and cardiomyopathy in young patients. Am J Med. 2007;120:165–171
  48. Antonilli L, Semeraro F, Suriano C, Signore L, Nencini P. High levels of morphine-6-glucuronide in street heroin addicts. Psychopharmacology (Berl). 2003;170:200–204

PII: S1756-2317(08)00205-3

doi: 10.1016/j.mpdhp.2008.11.001

Diagnostic Histopathology
Volume 15, Issue 1 , Pages 33-41 , January 2009

Article Tools